Crescent Capital BDC (NASDAQ:CCAP) Share Price Breaks Above 50 Day Moving Average – Here’s What Happened

Crescent Capital BDC, Inc. (NASDAQ:CCAP) shares crossed above its fifty day moving average during trading on Tuesday. The stock has a fifty day moving average of $9.44 and traded as high as $10.41. Crescent Capital BDC shares last traded at $10.38, with a volume of 533,794 shares traded.

Key Stories Impacting Crescent Capital BDC

Here are the key news stories impacting Crescent Capital BDC this week:

• Positive Sentiment: CCAP reported third-quarter net investment income of $0.37 per share, beating the $0.35 consensus estimate; revenue of $36.89 million also topped expectations. The company reported NAV of $17.72 per share at quarter-end. Zacks earnings coverage
• Positive Sentiment: The company authorized a $50 million share repurchase program and declared a quarterly base dividend of $0.34 per share, equivalent to $1.36 annualized. Buybacks may support per-share value, while the dividend remains a notable income feature. Company earnings and capital return announcement
• Neutral Sentiment: Analysts’ average price target suggests potential upside, and the company is targeting completion of a joint venture in the fourth quarter of 2026. Price targets are estimates, and the JV remains prospective. Analyst price target coverage Joint venture and buyback coverage
• Negative Sentiment: Quarterly earnings of $0.37 per share were below the $0.46 reported a year earlier. A separate report noted direct lending for buyouts fell 60% year over year, raising concerns about deal activity and future growth. Motley Fool analysis

Analyst Upgrades and Downgrades

Several brokerages have commented on CCAP. Raymond James Financial set a $10.00 price target on shares of Crescent Capital BDC in a research report on Thursday, October 22nd. LADENBURG THALM/SH SH decreased their price objective on Crescent Capital BDC from $15.00 to $14.00 and set a “buy” rating for the company in a report on Wednesday, August 12th. B. Riley Financial lowered their target price on Crescent Capital BDC from $13.50 to $12.50 and set a “neutral” rating on the stock in a research report on Wednesday, August 12th. Wells Fargo & Company dropped their target price on Crescent Capital BDC from $12.00 to $11.00 and set an “equal weight” rating on the stock in a report on Wednesday, August 12th. Finally, Zacks Research upgraded Crescent Capital BDC from a “strong sell” rating to a “hold” rating in a report on Tuesday, July 21st. One research analyst has rated the stock with a Buy rating and six have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, Crescent Capital BDC presently has an average rating of “Hold” and an average price target of $12.25.

Crescent Capital BDC Trading Up 12.3%

The company has a debt-to-equity ratio of 1.41, a quick ratio of 1.30 and a current ratio of 1.30. The firm has a fifty day moving average price of $9.44 and a 200 day moving average price of $11.53. The company has a market cap of $382.50 million, a price-to-earnings ratio of -1,038.00 and a beta of 0.56.

Crescent Capital BDC (NASDAQ:CCAP) last issued its earnings results on Monday, November 9th. The company reported $0.37 earnings per share for the quarter, topping analysts’ consensus estimates of $0.35 by $0.02. Crescent Capital BDC had a negative net margin of 0.10% and a positive return on equity of 8.66%. The business had revenue of $36.89 million for the quarter, compared to the consensus estimate of $36.37 million. As a group, equities analysts predict that Crescent Capital BDC, Inc. will post 1.49 EPS for the current fiscal year.

Crescent Capital BDC Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, January 15th. Shareholders of record on Thursday, December 31st will be paid a $0.34 dividend. The ex-dividend date is Thursday, December 31st. This represents a $1.36 dividend on an annualized basis and a yield of 13.1%. Crescent Capital BDC’s dividend payout ratio (DPR) is currently -1,511.11%.

Insider Activity

In other news, major shareholder & Guaranty Life Insur Fidelity sold 139,054 shares of the company’s stock in a transaction dated Wednesday, September 9th. The shares were sold at an average price of $10.23, for a total value of $1,422,522.42. Following the sale, the insider directly owned 3,680,307 shares of the company’s stock, valued at approximately $37,649,540.61. This represents a 3.64% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders have sold 451,543 shares of company stock valued at $4,689,738. 1.23% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Crescent Capital BDC

Institutional investors have recently bought and sold shares of the business. Fidelity National Financial Inc. acquired a new stake in shares of Crescent Capital BDC in the second quarter valued at approximately $45,922,000. Rivernorth Capital Management LLC acquired a new position in shares of Crescent Capital BDC during the 2nd quarter worth approximately $7,675,000. North Ground Capital acquired a new position in shares of Crescent Capital BDC during the 2nd quarter worth approximately $5,687,136. Beach Point Capital Management LP raised its stake in Crescent Capital BDC by 1,301.2% in the 3rd quarter. Beach Point Capital Management LP now owns 515,892 shares of the company’s stock valued at $4,736,000 after acquiring an additional 479,075 shares during the period. Finally, Almitas Capital LLC bought a new stake in Crescent Capital BDC in the 2nd quarter valued at $3,897,000. Institutional investors and hedge funds own 49.46% of the company’s stock.

Crescent Capital BDC Company Profile

Crescent Capital BDC, Inc. is a business development company that provides financing to middle-market companies. The company seeks to generate current income and, to a lesser extent, capital appreciation by investing in privately negotiated debt and equity securities. Its investment portfolio is focused primarily on senior secured loans, including first-lien and second-lien loans, as well as other debt investments and selected equity interests. Crescent Capital BDC generally works with established companies across a range of industries, providing capital for acquisitions, recapitalizations, refinancing, growth initiatives and other corporate purposes.